BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.81% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5326
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$489M
| $2.8K | ﹤0.01% |
+91
| New | +$2.71K |
2026 Q2
0 quarters
|
|
5327
Boxlight
BOXL
$1.6M
| $2.79K | ﹤0.01% |
592
-6
| -1% | -$33 |
2020 Q4
22 quarters
|
|
5328
Amber International Holding Ltd
AMBR
$164M
| $2.75K | ﹤0.01% |
1,845
| – | – |
2025 Q2
4 quarters
|
|
5329
Embotelladora Andina Series A
AKO.A
| $2.73K | ﹤0.01% |
124
| – | – |
2025 Q1
5 quarters
|
|
5330
Invesco S&P 500 BuyWrite ETF
PBP
$388M
| $2.7K | ﹤0.01% |
+118
| New | +$2.67K |
2026 Q2
0 quarters
|
|
5331
Adagene
ADAG
$137M
| $2.67K | ﹤0.01% |
635
| – | – |
2025 Q2
4 quarters
|
|
5332
Sohu.com
SOHU
$321M
| $2.38K | ﹤0.01% |
196
-1,069
| -85% | -$15.3K |
2015 Q3
43 quarters
|
|
5333
Aurelion Inc
AURE
$37.5M
| $2.36K | ﹤0.01% |
1,120
| – | – |
2023 Q3
11 quarters
|
|
5334
Fidelity Enhanced Large Cap Core ETF
FELC
$8.66B
| $2.3K | ﹤0.01% |
+55
| New | +$2.23K |
2026 Q2
0 quarters
|
|
5335
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.63B
| $2.24K | ﹤0.01% |
43
| – | – |
2025 Q4
2 quarters
|
|
5336
Pacer Data & Infrastructure Real Estate ETF
SRVR
$284M
| $2.22K | ﹤0.01% |
70
+8
| +13% | +$272 |
2025 Q2
4 quarters
|
|
5337
AEON Biopharma
AEON
$12.6M
| $2.04K | ﹤0.01% |
2,834
| – | – |
2023 Q3
11 quarters
|
|
5338
Global X SuperDividend US ETF
DIV
$773M
| $1.94K | ﹤0.01% |
102
+2
| +2% | +$38 |
2024 Q4
6 quarters
|
|
5339
AsiaStrategy
SORA
$59.7M
| $1.89K | ﹤0.01% |
979
| – | – |
2025 Q2
4 quarters
|
|
5340
Heart Test Laboratories
HSCS
$11.5M
| $1.88K | ﹤0.01% |
+750
| New | +$1.54K |
2026 Q2
0 quarters
|
|
5341
Theriva Biologics
TOVX
$7.16M
| $1.88K | ﹤0.01% |
7,504
| – | – |
2016 Q2
40 quarters
|
|
5342
Opendoor Technologies Inc Series K Warrants
OPENW
$910K
| $1.82K | ﹤0.01% |
3,669
-1,826
| -33% | -$1.1K |
2025 Q4
2 quarters
|
|
5343
iShares iBonds Dec 2032 Term Muni Bond ETF
IBMU
$15.1M
| $1.78K | ﹤0.01% |
70
-99,930
| -100% | -$2.53M |
2026 Q1
1 quarter
|
|
5344
Alliance Entertainment
AENT
$234M
| $1.75K | ﹤0.01% |
300
| – | – |
2026 Q1
1 quarter
|
|
5345
Baozun
BZUN
$205M
| $1.68K | ﹤0.01% |
595
-232
| -28% | -$626 |
2016 Q4
38 quarters
|
|
5346
iShares iBonds Dec 2031 Term Muni Bond ETF
IBMT
$159M
| $1.68K | ﹤0.01% |
65
| – | – |
2025 Q1
5 quarters
|
|
5347
ATS Corp
ATS
$1.67B
| $1.67K | ﹤0.01% |
58
| – | – |
2025 Q4
2 quarters
|
|
5348
CEMIG Ordinary Shares
CIG.C
$8.61B
| $1.56K | ﹤0.01% |
510
-1,341
| -72% | -$4.43K |
2024 Q1
9 quarters
|
|
5349
BitFuFu
FUFU
$140M
| $1.48K | ﹤0.01% |
1,052
| – | – |
2025 Q1
5 quarters
|
|
5350
Moleculin Biotech
MBRX
$8.86M
| $1.37K | ﹤0.01% |
25
| – | – |
2018 Q2
32 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 244 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 244 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.